ALLMedicine™ Secondary Prevention of Coronary Artery Disease Center
Research & Reviews 123 results
https://doi.org/10.2217/fca-2020-0211
Future Cardiology; Ortega-Paz L, Capodanno D et. al.
Feb 3rd, 2021 - Cardiovascular disease manifestations (CVD) are the world's leading cause of death, and their impact on morbidity requires effective prevention strategies of recurrent adverse events. For decades, inflammation has been proposed as a key promoter f...
https://doi.org/10.1016/j.clnesp.2020.11.006
Clinical Nutrition ESPEN; Dludla PV, Nkambule BB et. al.
Jan 25th, 2021 - There is a general interest in understanding how the consumption of tea impacts cardiovascular function in individuals at risk of developing cardiovascular disease (CVD). The current review focuses on evidence from randomized controlled trials (RC...
https://doi.org/10.1016/j.amjcard.2020.10.043
The American Journal of Cardiology; Xia M, Yang X et. al.
Nov 2nd, 2020 - Colchicine has shown potential therapeutic benefits in cardiovascular conditions owing to its broad anti-inflammatory properties. Here, we performed a meta-analysis to determine the efficacy and safety of colchicine in patients with coronary arter...
https://doi.org/10.5603/CJ.a2020.0072
Cardiology Journal; Jankowski P, Kosior DA et. al.
May 21st, 2020 - The highest priority in preventive cardiology is given to patients with established coronary artery disease (CAD). The aim of the study was to assess the current implementation of the guidelines for secondary prevention in everyday clinical practi...
https://doi.org/10.1016/j.atherosclerosis.2020.01.018
Atherosclerosis Leskelä RL, Torvinen A et. al.
Jan 30th, 2020 - Ischemic heart diseases are the main cause of death worldwide, therefore secondary prevention and treatment of coronary artery disease (CAD) are highly significant for public health and mortality. The objective of this study is to evaluate LDL cho...
Guidelines 3 results
https://doi.org/10.1177/2047487319876186
European Journal of Preventive Cardiology; Borjesson M, Dellborg M et. al.
Sep 13th, 2019 - This paper presents a brief summary of the recommendations from the Sports Cardiology section of the European Association of Preventive Cardiology (EAPC) on sports-participation in patients with coronary artery disease, coronary artery anomalies o...
https://www.ahajournals.org/doi/abs/10.1161/ATV.0000000000000073
Newman, C.
Dec 9th, 2018 - One in 4 Americans >40 years of age takes a statin to reduce the risk of myocardial infarction, ischemic stroke, and other complications of atherosclerotic disease. The most effective statins produce a mean reduction in low-density lipoprotein cho.
https://doi.org/10.1378/chest.08-0685
Chest Becker RC, Meade TW et. al.
Jul 23rd, 2008 - The following chapter devoted to antithrombotic therapy for chronic coronary artery disease (CAD) is part of the Antithrombotic and Thrombolytic Therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition...
Clinicaltrials.gov 127 results
https://doi.org/10.2217/fca-2020-0211
Future Cardiology; Ortega-Paz L, Capodanno D et. al.
Feb 3rd, 2021 - Cardiovascular disease manifestations (CVD) are the world's leading cause of death, and their impact on morbidity requires effective prevention strategies of recurrent adverse events. For decades, inflammation has been proposed as a key promoter f...
https://doi.org/10.1016/j.clnesp.2020.11.006
Clinical Nutrition ESPEN; Dludla PV, Nkambule BB et. al.
Jan 25th, 2021 - There is a general interest in understanding how the consumption of tea impacts cardiovascular function in individuals at risk of developing cardiovascular disease (CVD). The current review focuses on evidence from randomized controlled trials (RC...
https://doi.org/10.1016/j.amjcard.2020.10.043
The American Journal of Cardiology; Xia M, Yang X et. al.
Nov 2nd, 2020 - Colchicine has shown potential therapeutic benefits in cardiovascular conditions owing to its broad anti-inflammatory properties. Here, we performed a meta-analysis to determine the efficacy and safety of colchicine in patients with coronary arter...
https://doi.org/10.5603/CJ.a2020.0072
Cardiology Journal; Jankowski P, Kosior DA et. al.
May 21st, 2020 - The highest priority in preventive cardiology is given to patients with established coronary artery disease (CAD). The aim of the study was to assess the current implementation of the guidelines for secondary prevention in everyday clinical practi...
https://doi.org/10.1016/j.atherosclerosis.2020.01.018
Atherosclerosis Leskelä RL, Torvinen A et. al.
Jan 30th, 2020 - Ischemic heart diseases are the main cause of death worldwide, therefore secondary prevention and treatment of coronary artery disease (CAD) are highly significant for public health and mortality. The objective of this study is to evaluate LDL cho...
News 2 results
https://www.medpagetoday.com/cardiology/atherosclerosis/38117
Mar 27th, 2013 - Action Points Note that this systematic review demonstrated improved costs and outcomes among adherent patients in studies of primary or secondary prevention of coronary artery disease. Be aware that few studies contained an adequate control group...
https://www.mdedge.com/content/quality-guidelines-issued-ambulatory-cardiac-care-0
Alicia Ault
Jun 13th, 2011 - A group of professional societies on June 13 has issued the first set of quality improvement measures that focus on primary and secondary prevention of coronary artery disease and hypertension in the ambulatory setting. The 10 measures were charac.